Fracture Risk Prediction by Non-BMD DXA Measures: the 2015 ISCD Official Positions Part 2: Trabecular Bone Score
Barbara C. Silva(Hospital Felício Rocho), William D. Leslie(CancerCare Manitoba), Stéphanie Boutroy(Université Claude Bernard Lyon 1), Susan B. Broy(Rosalind Franklin University of Medicine and Science), John T. Schousboe(Park Nicollet Clinic), John Shepherd(Cancer Center of Hawaii)
Cited by 326
Related Papers
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
|Arthritis & Rheumatology|2015|2.8k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
|Arthritis Care & Research|2015|1.1k
A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis
|Arthritis & Rheumatism|2002|574
Executive Summary of the 2013 International Society for Clinical Densitometry Position Development Conference on Bone Densitometry
|Journal of Clinical Densitometry|2013|546